NASDAQ · IBB
iShares Biotechnology ETF
$217.61-$0.25 (-0.11%)
iShares Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
Loading market information…
CBOE · BBUS · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
JPMorgan BetaBuilders U.S. Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JPMorgan BetaBuilders U.S. Equity ETF’s forward annual dividend is $1.41 per share, paid quarterly. The forward yield is 1.03% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This exchange-traded fund tracks a benchmark index comprised mainly of U.S.-listed stocks. The index employs a free-float market capitalization weighting methodology, aiming to cover 85% of the total market value within its universe, with a strong emphasis on large and medium-sized corporations. The fund commits to holding at least 80% of its total investments in the components of this underlying index.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$217.61-$0.25 (-0.11%)
iShares Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$101.11-$4.88 (-4.6%)
iShares MSCI Taiwan ETF’s quoted price sits in the upper half of its reported 52-week range, 14.65% below the high.
$42.70-$0.73 (-1.68%)
Fidelity Enhanced Large Cap Core ETF’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
$98.57-$3.12 (-3.07%)
First Trust RBA American Industrial RenaissanceTM ETF’s quoted price sits in the lower half of its reported 52-week range, 27.01% below the high.
$42.82-$0.73 (-1.68%)
T. Rowe Capital Appreciation Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
$231.13-$1.91 (-0.82%)
Vanguard S&P 500 Value ETF’s quoted price sits in the upper half of its reported 52-week range, 0.82% below the high.
$62.75+$0.03 (+0.05%)
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$77.57-$0.79 (-1.01%)
JPMorgan BetaBuilders International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.17% below the high.
